5AM Venture Management »

Erasca shares owned by 5AM Venture Management

Quarter-by-quarter ownership of Erasca (ERAS) shares owned by 5AM Venture Management from 13F filings

Historical chart of 5AM Venture Management investment in Erasca

Tip: Access up to 7 years of quarterly data

All positions including Erasca held by 5AM Venture Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Erasca by 5AM Venture Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $13M 5.4M 2.36

More positions owned by 5AM Venture Management

Skye Bioscience Com New (SKYE)
Entrada Therapeutics (TRDA)
Enliven Therapeutics (ELVN)
Dianthus Therapeutics (DNTH)
Celldex Therapeutics Com New (CLDX)
Biohaven (BHVN)
Tyra Biosciences (TYRA)
Pharvaris N V (PHVS)
Praxis Precision Medicines I Com New (PRAX)
Erasca (ERAS)
Viking Therapeutics (VKTX)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Tectonic Therapeutic
Miragen Therapeutics (VRDN)

View all positions for 5AM Venture Management

Top funds holding Erasca

VR Adviser
Frazier Life Sciences Management
Suvretta Capital Management
Arch Venture Corp
BlackRock
Vanguard Group
Artal Group
Henderson Group
Silverarc Capital Management
T. Rowe Price Investment Management
Paradigm Biocapital Advisors
Logos Global Management
5AM Venture Management
Partner Fund Management
Balyasny Asset Management

View all funds holding Erasca